Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Leavitt, Glenn
NCT05264506: Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive	Terminated	3	2007	US	NOMAC-E2 COC, Nomegestrol acetate / estradiol	Organon and Co, IQVIA Inc., OSTAtistics	Contraception	01/24	01/24
NCT05399641: Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis	Completed	3	150	US	Ibrexafungerp	Scynexis, Inc.	Vulvovaginal Candidiasis	05/23	08/23
NCT05947084: Comparison of Growth and Tolerance of Healthy Term Infants Fed Iron-Fortified Infant Formulas	Recruiting	3	440	US	Infant Formula	Aussie Bubs, Inc.	Infant Development	08/24	09/24
PURSUIT, NCT04720352: Prospective US Radiofrequency SUI Trial	Recruiting	N/A	390	US	Active treatment, Sham	Viveve Inc.	Urinary Incontinence, Stress	12/22	12/22